Mesothelin promotes invasion and metastasis in breast cancer cells.
about
Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin-Targeting Recombinant ImmunotoxinsOverexpression of sulfatase-1 in murine hepatocarcinoma Hca-F cell line downregulates mesothelin and leads to reduction in lymphatic metastasis, both in vitro and in vivoMesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis.Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin.
P2860
Mesothelin promotes invasion and metastasis in breast cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mesothelin promotes invasion and metastasis in breast cancer cells.
@en
Mesothelin promotes invasion and metastasis in breast cancer cells.
@nl
type
label
Mesothelin promotes invasion and metastasis in breast cancer cells.
@en
Mesothelin promotes invasion and metastasis in breast cancer cells.
@nl
prefLabel
Mesothelin promotes invasion and metastasis in breast cancer cells.
@en
Mesothelin promotes invasion and metastasis in breast cancer cells.
@nl
P2093
P2860
P1476
Mesothelin promotes invasion and metastasis in breast cancer cells.
@en
P2093
P2860
P304
P356
10.1177/030006051204000608
P577
2012-01-01T00:00:00Z